, /PRNewswire/ --The global size is estimated to grow by .47 billion from 2024-2028, according to Technavio. The market is estimated to grow at a CAGR of 14.
75% during the forecast period. For more insights on the forecast market size and historic data (2018 - 2022) - The epigenetics market is experiencing significant growth due to the rising prevalence of chronic diseases and the demand for personalized medicine. Enzyme technology, including production, isolation, purification, and utilization of enzymes for synthetic drug assembly, is a key driver.
Researchers modify enzyme properties for desired functions like kinetics, thermal stability, and specificity, which are essential for gene expression studies. This technology is also utilized in pharmaceuticals for treating spinal injuries, nerve tissue regeneration, and SCID. Epigenetics is also linked to various health issues such as cancer, neurological disorders, and autoimmune diseases.
Key areas of focus include DNA methylation, epigenetic markers, and non-oncology conditions. Technological advancements in toxicoepigenetics, artificial intelligence (AI), and machine learning (ML) further expand market opportunities. Research report provides comprehensive data on impact of trend, driver and challenges - The epigenetics market experiences substantial growth in the healthcare sector, particularly in the oncology segment.
Epigenetic processes, such as DNA methylation and histone modification, play a crucial role in various dise.
